Marcos Szomstein, MD
Colon & Rectal Surgery · Miami, FLNPI 1497799761
Payments from drug & device makers
What this record shows
This record is dominated by education: $18,283 of the $21,530 with a category attached, or 84.9%. Intuitive Surgical accounts for 92.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $16,979 and has fallen 99.7% since, to $52 in 2025.
Across 89 payments — averaging $241.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$20K
- Braintree Laboratories, Inc.$455
- Virtual Incision Corporation$359
- Axonics, Inc.$137
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$119
- Medtronic$106
- plus $408 from 12 others
What the payments were for
- Travel & lodging$1,5807%
- Food & beverage$1,5437%
- Education$18,28385%
- Gifts$1251%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 17 | $19,947 |
| Braintree Laboratories, Inc. | 25 | $455 |
| Virtual Incision Corporation | 3 | $359 |
| Axonics, Inc. | 11 | $137 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $119 |
| Medtronic(2 entities) | 3 | $106 |
| Myriad Genetic Laboratories, Inc. | 4 | $89 |
| Ferring Pharmaceuticals Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Shire North American Group Inc | 2 | $38 |
| Sanara Medtech Inc. | 1 | $37 |
| Vioptix Inc | 2 | $30 |
| Activ Surgical, Inc. | 1 | $20 |
| AbbVie | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Cook Medical LLC | 1 | $13 |
| Pfizer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$17,500
- Da Vinci Surgical System$2,298
- Mira!$260
How this compares
$21,530 in reported general payments places this provider in the 75th percentile of 157 colon & rectal surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 184 | $29,822 |
| LinzessLinaclotide | 14 | $7,455 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 59 | $3,690 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 20 | $3,416 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 20 | $1,827 |
| Neomycin Sulfate | 118 | $722 |
| Hydrocortisone | 29 | $615 |
| Dicyclomine Hcl | 11 | $315 |
| Metronidazole | 120 | $199 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $126 |
| Tamsulosin Hcl | 99 | $84 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $84 |
| Gabapentin | 11 | $81 |
| Tramadol Hcl | 24 | $70 |
| Alprazolam | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Sutab | $455 | $29,822184 claims |
| AbbVieLinzess | $20 | $7,45514 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $72 | $3,41620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 157 colon & rectal surgery providers in Florida.
Other colon & rectal surgery in Miami
- Henry LujanMiami$378K
- Luis HernandezMiami$220K
- Laurence SandsMiami$47K
- Gustavo PlasenciaMiami$46K
- Marianna ZeichenMiami$44K
- Andrea MadiedoMiami$38K
- Eduardo KrajewskiMiami$29K
- Gustavo RubioMiami$14K
- Mark SolimanAltamonte Springs$872K
- Eduardo Parra DavilaWest Palm Beach$577K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.